en linked to their subsequent development and learning capacity. The investigators will
use magneto-encephalography (MEG), a technology which is new to Washington State. MEG measures
brain waves at the surface of the scalp in a non-invasive, noiseless process. This will be the only MEG in
the world devoted to children. The behaviors, syndromes, and disabilities that will be addressed by the
team represent unmet medical needs and are all prevalent in Washington State and worldwide. Improved
understanding of the causes and possible treatment of autism, ADHD, dyslexia, learning difficulties and
other diseases with early childhood onset will have profound implications for both the educational and
health-care systems.
Gerald Nepom, Benaroya Research Institute at Virginia Mason, $5,575,200
Program title: Program for Autoimmune Disease Intervention (PADI)
Program focus: To apply genetic and immunologic discoveries to benefit people with autoimmune
diseases, such as Type 1 diabetes, multiple sclerosis (MS) and systemic lupus erythematosis (lupus).
The investigators will pioneer immunologic staging or profiling as a tool for early diagnosis, selection of
treatment, monitoring of therapeutic response, and prediction of prognosis for Type 1 diabetes, MS, and
lupus, diseases of particularly high prevalence in Washington State. By suppressing an immune response
common to these three diseases, the investigators hope to improve basic diagnostic and treatment
capabilities. Disease management in Type 1 diabetes, MS, and lupus can only be done with general
immunosuppressive regimens that often create devastating side effects. Both regional and global markets
are desperately in need of new therapeutic options for treating autoimmunity. Profiling will also be used to
group those individuals eligible for clinical trials and therapies, create new therapeutic options, and
generate economic development in Washington State for new
'/>"/>
Page: 1 2 3 4 5 Related medicine news :1.
Life Sciences Discovery Fund Awards $2.2 Million to Support New Solid-Tumor Research Program2.
IC Sciences Investigates Application of Narrative Sciences for Medical Informatics Instruments3.
Edwards Lifesciences Announces Retirement of Director Vernon Loucks4.
Edwards Lifesciences to Host Earnings Conference Call on April 22, 20085.
IC Sciences Deepens Commitment to Pioneer Digital Informatics Instruments through New Medical Division6.
Leading Life Sciences Company Installs SafeMedias Network Security Management Appliance to Prevent Illegal Peer to Peer (P2P) File Sharing7.
Advanced Life Sciences to Host Conference Call to Discuss April 7th Meeting with FDA8.
Edwards Lifesciences Chairman and CEO Adopts New 10b5-1 Stock Trading Plan to Replace Recently Expired Plan9.
Derma Sciences Raises $6.1 Million Through Private Placement10.
CJPS Enterprises to Expand Efforts of 21st Century Jobs Fund Life Sciences Pipeline11.
Derma Sciences to Report 2007 Fourth Quarter and Year-End Results on April 1, 2008